BMS partners with drug accelerator to launch biotech

05-02-2020

Sarah Morgan

BMS partners with drug accelerator to launch biotech

Katherine Welles / Shutterstock.com

Bristol-Myers Squibb (BMS) and BioMotiv, a drug development accelerator, have launched Anteros Pharmaceuticals, a biotech focused on developing a new class of drugs for fibrotic and other inflammatory diseases.


BMS, Bristol-Myers Squibb, BioMotiv, Anteros Pharmaceuticals, drug development, biotech, research and development, inflammatory diseases

LSIPR